Tavipek (lavender essential oil) enteric soft capsules 0.15 g. №30

Description

Tavipek (lavender essential oil) enteric soft capsules 0.15 g. №30

Composition

active substance: 1 capsule contains 150 mg (0.15 g) of lavender essential oil;

Excipients: gelatin, glycerin, quinoline yellow (E 104), sunset yellow (E 110), methacrylate copolymer (type A), sodium lauryl sulfate, propylene glycol, polysorbate 80, glycerol monostearate.

Dosage form

The enteric capsules are soft.

Main physical and chemical properties: oval yellow intestinal soluble soft capsules with clear mobile light yellow or greenish-yellow liquid.

Pharmacotherapeutic group

Medications used in cough and catarrhal diseases. Expectorants.
ATX code R05C A.

Pharmacological properties

Tavipek has a secretolytic, expectorant, mucolytic, epithelial, anti-inflammatory, antimicrobial, immunostimulatory effect.

The secretolytic effect of the drug is manifested in increased mucociliary clearance. Mucolytic and expectorant action is due to the liquefaction of mucus and increased functional activity of the ciliated epithelium, which promotes faster and easier release of mucus from the respiratory tract. The antimicrobial and anti-inflammatory activity of Tavipek is due to the bactericidal and anti-inflammatory properties of lavender essential oil and is manifested in the inhibition of the overall growth of bacteria. Lavender essential oil in vitro inhibits the overall growth of bacteria and fungi, including Mycobacterium tuberculosis, without affecting the normal intestinal microflora. Tavipek inactivates staphylococcal toxin – alpha-hemolysin and streptococcal toxin – streptolysin, toxins released by pathogenic bacteria. Tavipek stimulates non-specific parts of the immune system by activating cellular immunity, increasing the phagocytic activity of leukocytes.

Indications

The drug is prescribed to treat the following symptoms of ARVI and ARI:

• acute bronchitis;
• Chronical bronchitis;
• bronchectasis;
• smoker’s cough;
• sinusitis.

Contraindications

The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or to one of the auxiliary components.
The drug is contraindicated for the following diseases:

• peptic ulcer;
• hyperacid gastritis;
• acute hepatitis;
• pancreatitis;
• nephritis.

In pediatrics, the drug is used after 12 years.

Application during pregnancy and lactation

This drug is not recommended for pregnant women – only for strict indications determined by the attending physician.
If it is necessary to take the drug during breastfeeding, lactation is suspended.

Method of administration and dosage

Adults and children over 12 years old take 1-2 capsules 3 times a day, do not chew, with meals.
The course of therapy depends on the nature and severity of the disease and is determined by the doctor individually.

Overdose

Overdose cases are not described. Nausea and other gastrointestinal complaints are suspected.

Side effects

The drug is usually well tolerated if used in the recommended doses and the regimen is followed.
Allergy may occur in case of individual intolerance. In particular, there may be observed:

• belching, short-term nausea, vomiting, abdominal pain, dysgeusia;
• allergic reactions, including skin rashes, hives;
• the smell of lavender oil is likely on exhalation.